Fulcrum Therapeutics, Inc. (FULC): Price and Financial Metrics
FULC Price/Volume Stats
| Current price | $2.99 | 52-week high | $13.70 |
| Prev. close | $3.01 | 52-week low | $2.86 |
| Day low | $2.95 | Volume | 782,400 |
| Day high | $3.06 | Avg. volume | 994,200 |
| 50-day MA | $3.41 | Dividend yield | N/A |
| 200-day MA | $7.19 | Market Cap | 161.28M |
FULC Stock Price Chart Interactive Chart >
Fulcrum Therapeutics, Inc. (FULC) Company Bio
Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies. Its product candidate includes Losmapimod and FTX-HbF. The company was founded by Michael R. Green, Danny Reinberg, Rudolf Jaenisch, Jeannie T. Lee, and Bradley E. Bernstein on August 18, 2015 and is headquartered in Cambridge, MA.
FULC Price Returns
| 1-mo | -11.80% |
| 3-mo | -67.39% |
| 6-mo | -58.53% |
| 1-year | -34.29% |
| 3-year | -80.33% |
| 5-year | -78.67% |
| YTD | -55.70% |
| 2023 | -7.28% |
| 2022 | -58.85% |
| 2021 | 51.07% |
| 2020 | -29.63% |
| 2019 | N/A |
Loading social stream, please wait...